https://medicalxpress.com/hiv-aids-news/ en-us Latest health news and information about HIV & AIDS Young people living with HIV manage their condition better when their antiretroviral therapy is given by injections every eight weeks rather than daily tablets, according to results of a trial in Africa led by UCL (University College London) researchers. https://medicalxpress.com/news/2026-09-hiv-tablets-young-people-clinical.html Thu, 17 Sep 2026 18:30:01 EDT news708781562 There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives. Results from a clinical trial led by Rockefeller, Imperial College London, and the University of Oxford (RIO) have offered a new strategy, suggesting that just one or two doses of broadly neutralizing antibodies (bNAbs) can suppress the virus long term, keeping it at undetectable levels for months and even years. https://medicalxpress.com/news/2026-09-immune-hiv.html Thu, 17 Sep 2026 15:00:08 EDT news708871262 Emory University researchers have provided the first proof of concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved cancer medication. Venetoclax effectively targets and blocks Bcl-2, a protein that not only regulates whether cells live or die but also promotes the survival of cancer cells. Similarly, Bcl-2 is a culprit in sustaining HIV cell reservoirs. https://medicalxpress.com/news/2026-09-cancer-medication-siv-reservoir-hiv.html Thu, 03 Sep 2026 16:20:01 EDT news707652687 HIV (human immunodeficiency virus) is a virus that attacks the body's immune system and remains a major global health challenge because of persistent viral reservoirs, despite effective treatments. Key factors include around 40 million people living with HIV, 1 million new infections each year and permanent viral DNA integration into host cells. Some HIV proviruses hide quietly in cells and escape both medicines and the immune system, creating a permanent viral reservoir that prevents patients from being cured. https://medicalxpress.com/news/2026-08-hiv-proviruses-chronic-inflammation.html Mon, 10 Aug 2026 16:40:08 EDT news705587822 Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon Health & Science University suggests another possibility: a one-time regimen of therapies given to newborns within three days of birth to permanently clear the virus. The research is published today in the journal Nature Microbiology. https://medicalxpress.com/news/2026-08-triple-dose-regimen-permanently-hiv.html Mon, 10 Aug 2026 05:00:03 EDT news705246781 A new biostatistical modeling approach has the potential to support health decisions by pinpointing where HIV is concentrated and where people living with HIV are showing signs of severe immune suppression or delayed treatment. Published in iScience, the study shows the potential of using existing health data to identify both where HIV burden is concentrated and where different forms of prevention, treatment and support may be needed. https://medicalxpress.com/news/2026-08-hiv-disease-advanced.html Wed, 05 Aug 2026 12:20:01 EDT news705148262 If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the "gold standard," dolutegravir (DTG). Now, another once-daily, three-drug regimen has been found to be as effective as DTG in suppressing HIV viral load. https://medicalxpress.com/news/2026-08-doravirine-dolutegravir-suppress-hiv-viral.html Mon, 03 Aug 2026 12:00:04 EDT news704977021 Scientists at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in a nonhuman primate model of HIV/AIDS. https://medicalxpress.com/news/2026-07-probiotic-derived-bioactive-metabolite-reverses.html Thu, 30 Jul 2026 18:00:03 EDT news704646164 An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as current leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking. https://medicalxpress.com/news/2026-07-international-weekly-hiv-pill-daily.html Thu, 30 Jul 2026 10:40:10 EDT news704625722 The odds of human papillomavirus (HPV)-related cancers are higher among people with HIV (PWH) and solid-organ transplant recipients (SOTRs), according to a study published in JAMA Network Open. https://medicalxpress.com/news/2026-07-odds-hpv-cancers-people-hiv.html Mon, 13 Jul 2026 20:40:06 EDT news703143827 Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the models may unintentionally repeat those biases in their responses. As their use increases with the rise of generative AI, it has become evident that they contain biases that reinforce stereotypes based on factors like ethnicity, gender or geography. This is concerning because LLM-based chatbots have become an integral part of the health care system, where health-related stigma can negatively affect one's diagnosis and care. https://medicalxpress.com/news/2026-07-medical-ai-biased-paper.html Thu, 09 Jul 2026 08:20:05 EDT news702801724 A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate a high number of "broadly neutralizing" virus-fighting antibodies in primates. The research is published in the journal Nature. https://medicalxpress.com/news/2026-07-hiv-vaccine-triggers-broadly-neutralizing.html Mon, 06 Jul 2026 16:30:02 EDT news702571560